Optimizing Axillary Management in Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy. Mitri S, Manfroi LM, Pannu PR, Means J, et al. Clin Breast Cancer 2025 Mar 31:S1526-8209(25)00088.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mitri S, Manfroi LM, Pannu PR, Means J, et al. Optimizing Axillary Management in Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy. Clin Breast Cancer 2025 Mar 31:S1526-8209(25)00088.
PMID: 40288933